Skip to main content

Table 1 The inhibition of β-catenin expression by ShRNA or MSeA is associated with drug-induced growth inhibition of tumor cells

From: Targeting the oncogenic protein beta-catenin to enhance chemotherapy outcome against solid human cancers

HCT-8 cell line

% cell growth inhibition

Beta-catenin expression

Control

0%

++++/strong

MSeA (1 μM)

~50%

++/weak

SN-38(0.7 μM)

~20%

++++/strong

MSeA+SN-38

>95%

+/very weak

ShRNA

0%

++/weak

ShRNA+SN38

~70%

+/very weak